PFIZER INC — Director's Dealing 2009

Mar 3, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2009-02-26

Reporting Person: MACKAY MARTIN (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-02-26	Common Stock	A	99868	—	Acquired	266304.00	Direct
2009-02-26	Common Stock	A	37114	—	Acquired	303418.00	Direct
2009-02-26	Common Stock	F	5837	$12.70	Disposed	297581.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-02-26	Phantom Stock Units	$	A	4234	Acquired		Common Stock (4234.00)	Direct
2009-02-26	Stock Appreciation Rights	$12.70	A	83955	Acquired	2014-02-26	Common Stock (83955.00)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	11586.00	Indirect

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units.

F2: The reported transaction constitutes the earn-out of Performance-Contingent Shares and Performance Shares.

F3: Each unit represents one phantom share of common stock.

F4: Units represent incentive compensation that has been deferred. Units will be settled in cash following separation from service.

F5: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant